These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30039368)

  • 1. Detection of CNVs in NGS Data Using VS-CNV.
    Fortier N; Rudy G; Scherer A
    Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.
    Agaoglu NB; Unal B; Akgun Dogan O; Zolfagharian P; Sharifli P; Karakurt A; Can Senay B; Kizilboga T; Yildiz J; Dinler Doganay G; Doganay L
    Expert Rev Mol Diagn; 2022 Feb; 22(2):239-246. PubMed ID: 35240897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number variant detection using next-generation sequencing in EYS-associated retinitis pigmentosa.
    Hiraoka M; Urakawa Y; Kawai K; Yoshida A; Hosakawa J; Takazawa M; Inaba A; Yokota S; Hirami Y; Takahashi M; Ohara O; Kurimoto Y; Maeda A
    PLoS One; 2024; 19(6):e0305812. PubMed ID: 38913662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model.
    Kozareva V; Stroff C; Silver M; Freidin JF; Delaney NF
    BMC Med Genomics; 2018 Oct; 11(1):91. PubMed ID: 30342520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
    Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
    J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Genetic Rearrangements in the Regulators of Complement Activation RCA Cluster by High-Throughput Sequencing and MLPA.
    García-Fernández J; Vilches-Arroyo S; Olavarrieta L; Pérez-Pérez J; Rodríguez de Córdoba S
    Methods Mol Biol; 2021; 2227():159-178. PubMed ID: 33847941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial approach to estimate copy number genotype using whole-exome sequencing data.
    Hwang MY; Moon S; Heo L; Kim YJ; Oh JH; Kim YJ; Kim YK; Lee J; Han BG; Kim BJ
    Genomics; 2015 Mar; 105(3):145-9. PubMed ID: 25535679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
    Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
    Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of exon-level copy number variants in CytoScan XON assay and next-generation sequencing in clinical samples.
    Won D; Yeom E; Shin S; Lee ST; Rak Choi J
    Clin Chim Acta; 2024 Jun; 560():119703. PubMed ID: 38763467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noise cancellation using total variation for copy number variation detection.
    Zare F; Hosny A; Nabavi S
    BMC Bioinformatics; 2018 Oct; 19(Suppl 11):361. PubMed ID: 30343665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High positive predictive value of CNVs detected by clinical exome sequencing in suspected genetic diseases.
    Zeng Y; Ding H; Wang X; Huang Y; Liu L; Du L; Lu J; Wu J; Zeng Y; Mai M; Zhu J; Yu L; He W; Guo F; Peng H; Yao C; Qi Y; Liu Y; Li F; Yang J; Hu R; Liang J; Wang J; Wang W; Zhang Y; Yin A
    J Transl Med; 2024 Jul; 22(1):644. PubMed ID: 38982507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SavvyCNV: Genome-wide CNV calling from off-target reads.
    Laver TW; De Franco E; Johnson MB; Patel KA; Ellard S; Weedon MN; Flanagan SE; Wakeling MN
    PLoS Comput Biol; 2022 Mar; 18(3):e1009940. PubMed ID: 35294448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
    Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
    Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.